Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668655 · ClinicalTrials.gov registry record
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
A clinical trial, sponsored by Galderma R&D.
- Completed
- Registry status
- 30
- Enrollment target
NCT00668655 is a clinical trial that has completed, run by Galderma R&D. The registered enrollment target is 30 participants.
The verdict
NCT00668655 has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
Interventions
- DRUG Metronidazole Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00668655
The ClinicalTrials.gov registry entry for NCT00668655 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metronidazole Gel is the first listed.
NCT00668655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00668655 about?
NCT00668655 is a clinical study titled "An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%". The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
What is the current status of trial NCT00668655?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00668655?
The interventions under investigation include: Metronidazole Gel (DRUG).
Who is sponsoring clinical trial NCT00668655?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.